- Daiichi Sankyo, Inc. (Bernards, NJ)
- …includes strategic partnerships with the brand team, HEOR (Health Economics and Outcomes Research ), RD ( Research Development ), FMA (Field Medical Affairs), ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Novo Nordisk Inc. (Hackensack, NJ)
- …class therapies for the treatment of diabetes, obesity, and the reduction of adverse cardiovascular events. As part of the team, you will have frontline exposure to ... passion and engagement are met with opportunities for professional and personal development . Are you ready to realize your potential? The Position This position… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …with key stakeholders within CSPV and external functions including Clinical Development , Research Development , Regulatory Affairs.Facilitate operational ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: The purpose… more
- Merck & Co. (Rahway, NJ)
- …the Global Regulatory Affairs and Clinical Safety (GRACS) function of Our Company's Research Laboratories ( Research & Development ) by:Developing an active ... and company strategy.Providing quality advice to stakeholders creating optimal development , commercialization, and drug/delivery device supply strategies-Building our leadership… more
- Formation Bio (New York, NY)
- …and AI driven pharma company differentiated by radically more efficient drug development . Advancements in AI and drug discovery are creating more candidate drugs ... because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: Provide leadership… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Responsibilities- GLOBAL… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …execution plans across and effective alignment within (eg with translational research , clinical operations, clinical development , medical affairs CSPV and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: Responsibility for… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: The Senior… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryDeliver the … more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryThe Regulated… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: Oversees typically… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryThis position is… more
- Novo Nordisk Inc. (Boston, MA)
- …class therapies for the treatment of diabetes, obesity, and the reduction of adverse cardiovascular events. As part of the team, you will have frontline exposure to ... where passion and engagement are met with opportunities for professional and personal development . Are you ready to realize your potential? The Position This role… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disordersJob Summary: The Regulatory… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Responsibilities:Supports positions… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryThe Business Architect… more
- UNC HEALTH (Raleigh, NC)
- Cardiovascular Surgery Stepdown Unit The Cardiovascular Surgical Stepdown Unit is located on the 5th floor of the Heart and Vascular Hospital. This stepdown unit ... patients with increased oxygen demands, needing advanced non-invasive oxygen delivery. The Cardiovascular Stepdown Unit is designed for patients who have moved out… more
